Drugs that contain Bivalirudin

1. Drug name - ANGIOMAX

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7598343 SANDOZ INC Pharmaceutical formulations of bivalirudin and processes of making the same Jul, 2028

(5 years from now)

US7582727 SANDOZ INC Pharmaceutical formulations of bivalirudin and processes of making the same Jul, 2028

(5 years from now)

US7582727

(Pediatric)

SANDOZ INC Pharmaceutical formulations of bivalirudin and processes of making the same Jan, 2029

(6 years from now)

US7598343

(Pediatric)

SANDOZ INC Pharmaceutical formulations of bivalirudin and processes of making the same Jan, 2029

(6 years from now)

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
250MG/VIAL INJECTABLE;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.